N. Blumstein

发表

Improved non-invasive T-Staging in non-small cell lung cancer by integrated18F-FDG PET/CT

F. Mottaghy, G. Glatting, A. Buck, 2007, Nuklearmedizin.

Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases.

G. Glatting, S. Reske, A. Schulz, 2011, Blood.

Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours

F. Mottaghy, A. Buck, S. Reske, 2006, Journal of internal medicine.

Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia.

G. Glatting, S. Reske, K. Hohl, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemia.

F. Mottaghy, G. Glatting, A. Buck, 2008, Cancer biotherapy & radiopharmaceuticals.

[PET and PET/CT in relapsing prostate carcinoma].

G. Glatting, S. Reske, N. Blumstein, 2006, Der Urologe. Ausg. A.

Superior Vena Cava Syndrome in Thoracic Malignancies

C. Schumann, N. Blumstein, R. Bals, 2011, Respiratory Care.

[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy

G. Glatting, S. Reske, N. Blumstein, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[11C]Choline PET/CT for Targeted Salvage Lymph Node Dissection in Patients with Biochemical Recurrence after Primary Curative Therapy for Prostate Cancer

Richard E. Hautmann, Felix M. Mottaghy, F. Mottaghy, 2008, Urologia Internationalis.

Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET

A. Buck, S. Reske, N. Blumstein, 2008, Nuklearmedizin.

Dosimetry with (188)Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.i.

G. Glatting, A. Buck, S. Reske, 2006, Nuklearmedizin. Nuclear medicine.

Dosimetry with 188Re-labelled monoclonal anti-CD66 antibodies

G. Glatting, A. Buck, S. Reske, 2006, Nuklearmedizin.

188Re or 90Y‐labelled anti‐CD66 antibody as part of a dose‐reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I–II study

H. Döhner, G. Glatting, A. Buck, 2005, British journal of haematology.

A 25-year-old woman with a gastric GIST and a PET-positive epicardial tumor

F. Mottaghy, S. Reske, M. Jeltsch, 2007, Nature Clinical Practice Oncology.

Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience.

Gerhard Glatting, Sven N Reske, G. Glatting, 2007, Radiology.

Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.

R. Schlenk, H. Döhner, G. Glatting, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.

J. Vose, B. Cheson, F. Mottaghy, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma

F. Mottaghy, G. Glatting, A. Buck, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma

F. Mottaghy, G. Glatting, A. Buck, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Internal radionuclide therapy: The ULMDOS software for treatment planning.

Michael Landmann, Thomas Kull, Gerhard Glatting, 2005, Medical physics.

Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma.

N. Blumstein, C. Evers, H. Schreiber-Facklam, 2010, International journal of radiation oncology, biology, physics.

Imaging prostate cancer with 11C-choline PET/CT.

Sven Perner, Gerhard Glatting, Sven N Reske, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Evaluation of [11C]‐choline positron‐emission/computed tomography in patients with increasing prostate‐specific antigen levels after primary treatment for prostate cancer

F. Mottaghy, S. Reske, R. Kuefer, 2007, BJU international.

Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases.

N. Blumstein, W. Luboldt, M. Seemann, 2008, Radiology.

11C‐Choline positron‐emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer

F. Mottaghy, S. Reske, R. Hautmann, 2007, BJU International.

Intensity-Modulated Radiotherapy for a Rendu-Osler-Weber Disease Patient with Recurrent Severe Epistaxis: A Case Report

N. Blumstein, C. Belka, M. Niyazi, 2010, Case reports in medicine.

Internal radionuclide therapy: the ULMDOS software for treatment planning.

G. Glatting, A. Buck, S. Reske, 2005, Medical physics.

[18F]Dihydroxyphenylalanine-PET/CT in pheochromozytoma

F. Mottaghy, A. Buck, S. Reske, 2007 .